Topic
Tom Bilyeu
In this pivotal discussion, Harvard geneticist David Sinclair reframes aging from an inevitable decline to a loss of biological information that can be controlled and potentially reversed. The conversation begins with a sobering anecdote about a 40-year-old poker dealer who suffered a fatal stroke o …
Andrew Huberman
Dr. Alex Marson and Andrew Huberman explore a transformative era in biology where medicine has shifted from observation to direct intervention at the root causes of disease, particularly cancer. The conversation highlights CAR-T cell therapy as a prime example of this convergence, utilizing chimeric …